Merck KGaA invests 250 million € in its Nantong plant.

The investment is split in 170 million € for Nantong pharmaceutical base which will focus on the production of high quality Chinese medicine. In the inauguration ceremony, Merck also announced the establishment of life science center in Nantong with an investment of 80 million euros, specializing in the production of high purity inorganic salts and cell culture medium.

China Bio news release, November 7, 2016

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny